Oxysterols and multiple sclerosis: Physiopathology, evolutive biomarkers and therapeutic strategy-Reference-Cited by-同舟云学术

Oxysterols and multiple sclerosis: Physiopathology, evolutive biomarkers and therapeutic strategy

Published:2021-06 Issue: Volume:210 Page:105870
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Vejux Anne^ORCID,Ghzaiel Imen,Nury Thomas,Schneider Vincent,Charrière Karine^ORCID,Sghaier Randa,Zarrouk Amira,Leoni Valerio,Moreau Thibault,Lizard Gérard^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference117 articles.

1. Multiple sclerosis review;Goldenberg;P T,2012

2. Multiple sclerosis;Gaby;Glob. Adv. Health Med.,2013

3. Pathological mechanisms in progressive multiple sclerosis;Mahad;Lancet Neurol.,2015

4. Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis;Sedel;Neuropharmacology,2016

5. Multiple sclerosis;Keegan;Annu. Rev. Med.,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a mechanism promoting mitochondrial sterol accumulation during myocardial ischemia–reperfusion: role of TSPO and STAR;Basic Research in Cardiology;2024-03-22

2. Cholestenoic acid as endogenous epigenetic regulator decreases hepatocyte lipid accumulation in vitro and in vivo;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-02-01

3. Oxy- and Phytosterols as Biomarkers: Current Status and Future Perspectives;Implication of Oxysterols and Phytosterols in Aging and Human Diseases;2023-12-01

4. Role of Oxysterols in Ocular Degeneration Mechanisms and Involvement of P2X7 Receptor;Implication of Oxysterols and Phytosterols in Aging and Human Diseases;2023-12-01

5. Insight into Early Diagnosis of Multiple Sclerosis by Targeting Prognostic Biomarkers;Current Pharmaceutical Design;2023-09